Altogether, these data, along with the recently reported ability of the enzyme to enhance INSR signaling in myeloma [15], prompted us to hypothesize that heparanase may play an important role in diabetes-associated breast cancer, facilitating tumor aggressiveness under hyperinsulinemic state. This evidence concerns the gene HPSE and diabetes mellitus.